The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer

Signal Transduct Target Ther. 2020 Aug 25;5(1):168. doi: 10.1038/s41392-020-00283-8.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Cell- and Tissue-Based Therapy
  • Clustered Regularly Interspaced Short Palindromic Repeats
  • Feasibility Studies
  • Humans
  • Lung Neoplasms* / drug therapy
  • T-Lymphocytes